Creative Biolabs: Riding the Wave in Immunotherapy Research and Development
New York, USA – December 18, 2023 – Immunotherapy has seen groundbreaking advancements in recent years, providing promising potential to transform treatment plans across a range of diseases, most notably cancer. The complement system and immune checkpoints in immunotherapy show tremendous potential in effectively treating diseases. Creative Biolabs, with its commitment to state-of-the-art technologies and the latest research, confidently offers a diverse range of services to propel ongoing immunotherapy research.
In bolstering complement therapeutic research, Creative Biolabs highlights two key services: aptamer development and complement therapeutic services centered on the C5 target. Leveraging a well-constructed SELEX technology platform, the company is poised to deliver aptamer development services tailored to diverse target forms.
A scientist at Creative Biolabs emphasized, “C5 plays a pivotal role in complex diseases such as sepsis or age-related macular degeneration, fueling ongoing research to unveil potential therapeutic targets surrounding C5 and related components.” The company takes pride in extending complement therapeutic target-C5 services for a spectrum of disorders, encompassing, but not limited to, Meningococcal Infection.
Furthermore, recognizing the pivotal role of immune checkpoints in regulating the immune system, Creative Biolabs harnesses advanced technologies to provide top-tier services to accelerate immune checkpoint therapy research. These include immune checkpoint targeted peptide design and structure-based immune checkpoint drug design services.
Creative Biolabs stands as a trusted provider of structure-based immune checkpoint drug design services for the immunotherapy industry. With extensive expertise in drug design and structural biology, the company employs cutting-edge technologies such as X-ray crystallography, protein NMR spectroscopy, homology modeling, and small molecule docking to meet the specific needs of global customers and support their immunotherapy projects.
High-quality peptide design services are highlighted below, and customers can make a choice based on their project needs:
* Protein structure-based peptide design
* Protein interaction-based peptide design
The representative scientist of Creative Biolabs expressed his enthusiasm about the company’s progress, stating, “Our dedication to advancing immunotherapy research is unwavering. By focusing on complement therapeutic and immune checkpoint therapy research, we are confident in our ability to provide comprehensive solutions to researchers in need.”
For more information on immunotherapy research services at Creative Biolabs, visit https://www.creative-biolabs.com/complement-therapeutics.
About Creative Biolabs
Creative Biolabs is a distinguished biotechnology company dedicated to pioneering solutions in immunotherapy research. With a team of experienced scientists and cutting-edge facilities, their primary goal is to advance the development of groundbreaking and efficient therapies for various diseases.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/complement-therapeutics
